Matthew Rhodes-Kropf is an Associate Professor in the Entrepreneurial Management Unit at Harvard Business School, where he teaches the "Venture Capital and Private Equity" course in the MBA elective curriculum. He specializes in mergers and acquisitions, venture capital, hedge funds, and corporate governance, and has published in leading finance and economic journals including The Journal of Finance, The Journal of Business, Journal of Financial Economics, and The RAND Journal of Economics. His 2004 paper “Market Valuation and Merger Waves,” published in The Journal of Finance, was nominated for the Brattle Prize for Best Paper in Corporate Finance in 2005.
Professor Rhodes-Kropf founded RK Ventures, an early-stage venture capital company with a focus on finance, technology, and biotech companies. RK Ventures-funded companies – including Rackspace (NYSE: RAX), Redpoint Bio (OTC: RPBC), Avid Radiopharmaceuticals, iCor Brokerage, and Axioma – have gone on to raise an aggregate of over $200 million from leading institutions. Professor Rhodes-Kropf has served as acting CFO of Avid Radiopharmaceuticals and has been a member of its board of directors since its founding. He is also a director of Credit Where Credit Is Due, a nonprofit credit union and financial education program focused on low-income individuals; a member of the board of advisors of Ada Investment Management, a process driven hedge fund that uses long- run economic signals, and Correlation Ventures, a quantitatively based venture fund.
Professor Rhodes-Kropf was formerly the Daniel W. Stanton Associate Professor of Business at the Columbia University Graduate School of Business, where he received the Dean’s Award for Teaching Excellence. A graduate of Duke University, Professor Rhodes-Kropf holds a BA in computer science and economics and an MA and Ph.D. in economics.